Herantis Pharma Plc announced the full-time appointment of Magnus Sjögren, MD, PhD as Chief Medical Officer. Dr. Sjögren will assume the role of Chief Medical Officer effective as of 1 May 2021. Dr. Sjogren is a neuroscience expert with a focus on neurodegenerative diseases, and in addition has experience in other areas relevant to Herantis' programs including oncology and inflammation. He has held several senior executive and scientific positions at major pharmaceutical and biotechnology companies, including Chief Medical Officer at DiaGenic, Vice President Global Exploratory Development at UCB Pharma, Global Head of Translational Medicine in Schering-Plough and Senior Clinical Research Director at AstraZeneca.